The9-backed Nanyang Biologics to go public via $1.5B SPAC merger

 

• Nanyang Biologics, backed by The9 Limited (NASDAQ:NCTY), will merge with SPAC RF Acquisition Corp II (NASDAQ:RFAI) to become publicly listed on Nasdaq.
• The combined company will trade under the reserved ticker symbol “NYB” after closing.
• The deal values NYB at a $1.5B pre-transaction equity value.
• NYB shareholders, including The9, will roll over 100% of their equity and retain majority ownership and board control.
• The transaction has board approval and is expected to close in Q1 or Q2 2026.
• NYB will leverage its AI platform to speed up drug discovery and develop natural ingredient-based therapies.
• NCTY shares up 13% premarket on Thursday.
• Source: Press release

https://www.msn.com/en-us/money/companies/the9-backed-nanyang-biologics-to-go-public-via-1-5b-spac-merger-shares-up/ar-AA1NJTAk